Tech Earnings Power Modest Rally; Healthcare Joins the Surge

U.S. equities opened Thursday with a measured climb, as solid corporate earnings helped absorb overnight headwinds from currency swings and inflation concerns abroad. The S&P 500 gained 0.44% to 765.16, while the Russell 2000 outpaced broader indices with a 1.18% jump, signaling appetite for smaller, domestically-focused names. The Nasdaq 100 advanced a more subdued 0.23%, reflecting tech's complicated earnings season.

The Earnings Engine Fires

Dell Technologies led the charge with a stunning +15.8% surge after posting a 43% EPS beat and 5% revenue beat, underscoring robust demand for AI-adjacent infrastructure and servers. The company's outperformance highlights a bifurcated tech landscape: while mega-cap semiconductors struggle with sell-the-news dynamics—witness AVGO's 5% decline despite reporting $16.7B AI revenue (+221% YoY)—infrastructure and systems play beneficiaries are capturing investor attention.

Healthcare stole the spotlight overnight, with three names cracking the top five gainers. RGC (+14.7%) and MLYS (+13.6%) joined TARS (+11.8%) in dramatic rallies, likely fueled by strong earnings prints. The broader healthcare sector gained 1.38%, outperforming most industrial peers and suggesting healthcare is rotating into favor as investors reassess valuations across the board.

Small-Cap Appetite Signals a Shift

The Russell 2000's outperformance—up 1.18% versus the S&P's 0.44%—hints at a meaningful rotation out of mega-cap concentration. This aligns with analyst commentary flagging several small and mid-cap stocks with multiple bullish signals converging: Dollar General (DG), Phibro Animal Health (PAHC), and Frontline Plc (FRO) all showing 2-3 bullish indicators. Such breadth in buy signals suggests institutional money is scouting the broader market rather than chasing the Magnificent Seven.

Currency Volatility and Inflation Creep

Overseas, the yen's surge created friction, with reports flagging Bank of Japan intervention risks. Additionally, Swiss inflation edged higher in August as Middle East tensions pushed global energy costs, reversing recent disinflationary trends. These cross-currents kept tech and financials subdued: Technology rose only 0.29% despite Dell's monster day, while Financial Services gained a bare 0.43%.

On a positive note, U.S. and European bond yields retreated from multiyear highs, and European equities recovered from a three-day decline as the global selloff eased. This is a crucial signal: if the Fed policy pivot materializes more clearly, yield-sensitive sectors could accelerate gains.

What to Watch

Today's agenda lacks major economic data, but earnings remain the focal point. Watch for continued healthcare strength and whether small-cap momentum sustains into Friday. Monitor Bitcoin, which held the $76K support level after dipping from $79K—a potential risk-on indicator if it breaks higher. Finally, track sentiment around Moderna (MRNA) following UBS's Sell downgrade; biotech sector headwinds could deepen if the selloff cascades.

The overarching narrative: earnings quality is driving rotation away from concentrated mega-cap plays. If this broadens, smaller names with solid fundamentals could dominate the next phase of this cycle.